PD-L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy. (2017)
Attributed to:
Molecular Determinants of Radiosensitivity
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.15252/emmm.201606674
PubMed Identifier: 27932443
Publication URI: http://europepmc.org/abstract/MED/27932443
Type: Journal Article/Review
Volume: 9
Parent Publication: EMBO molecular medicine
Issue: 2
ISSN: 1757-4676